Profile | GDS5420 / 238240_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 146.45 | 47 |
GSM1296119 | B_lesional_pre-dose | 82.54 | 37 |
GSM1296076 | C_lesional_pre-dose | 56.64 | 33 |
GSM1296092 | D_lesional_pre-dose | 71.39 | 39 |
GSM1296103 | E_lesional_pre-dose | 112.67 | 44 |
GSM1296078 | F_lesional_pre-dose | 101.41 | 43 |
GSM1296107 | G_lesional_pre-dose | 150.12 | 47 |
GSM1296109 | H_lesional_pre-dose | 124.83 | 43 |
GSM1296080 | I_lesional_pre-dose | 83.12 | 40 |
GSM1296090 | J_lesional_pre-dose | 84.98 | 40 |
GSM1296074 | K_lesional_pre-dose | 63.2 | 37 |
GSM1296111 | L_lesional_pre-dose | 156.82 | 47 |
GSM1296099 | M_lesional_pre-dose | 148.4 | 47 |
GSM1296086 | O_lesional_pre-dose | 60.45 | 35 |
GSM1296117 | P_lesional_pre-dose | 251.09 | 55 |
GSM1296113 | Q_lesional_pre-dose | 193.28 | 50 |
GSM1296096 | R_lesional_pre-dose | 142.63 | 47 |
GSM1296105 | S_lesional_pre-dose | 130.92 | 45 |
GSM1296098 | T_lesional_pre-dose | 156.4 | 48 |
GSM1296101 | U_lesional_pre-dose | 131.28 | 45 |
GSM1296121 | V_lesional_pre-dose | 62.34 | 33 |
GSM1296088 | W_lesional_pre-dose | 50.48 | 32 |
GSM1296082 | X_lesional_pre-dose | 80.44 | 40 |
GSM1296115 | Y_lesional_pre-dose | 192.69 | 51 |
GSM1296084 | Z_lesional_pre-dose | 48.82 | 30 |
GSM1296072 | B_lesional_day8 | 118.87 | 43 |
GSM1296069 | L_lesional_day8 | 226.14 | 53 |
GSM1296071 | P_lesional_day8 | 212.11 | 51 |
GSM1296070 | Y_lesional_day8 | 256.3 | 55 |
GSM1296073 | V_lesional_day8 | 125.19 | 45 |
GSM1296034 | A_lesional_day15 | 155.44 | 47 |
GSM1296041 | G_lesional_day15 | 170.11 | 49 |
GSM1296035 | R_lesional_day15 | 105.6 | 43 |
GSM1296038 | U_lesional_day15 | 146.83 | 47 |
GSM1296047 | B_lesional_day15 | 119.65 | 42 |
GSM1296039 | E_lesional_day15 | 116.94 | 44 |
GSM1296042 | H_lesional_day15 | 174.46 | 49 |
GSM1296043 | L_lesional_day15 | 232.82 | 53 |
GSM1296037 | M_lesional_day15 | 143.37 | 46 |
GSM1296046 | P_lesional_day15 | 213.68 | 52 |
GSM1296044 | Q_lesional_day15 | 194.69 | 50 |
GSM1296045 | Y_lesional_day15 | 226.34 | 53 |
GSM1296025 | C_lesional_day15 | 38.47 | 27 |
GSM1296033 | D_lesional_day15 | 73.75 | 37 |
GSM1296027 | I_lesional_day15 | 55.15 | 35 |
GSM1296032 | J_lesional_day15 | 50.95 | 31 |
GSM1296024 | K_lesional_day15 | 43.37 | 30 |
GSM1296031 | W_lesional_day15 | 49.11 | 30 |
GSM1296028 | X_lesional_day15 | 53.54 | 32 |
GSM1296029 | Z_lesional_day15 | 64.38 | 35 |
GSM1296026 | F_lesional_day15 | 52.32 | 31 |
GSM1296030 | O_lesional_day15 | 45.07 | 33 |
GSM1296040 | S_lesional_day15 | 197.05 | 52 |
GSM1296036 | T_lesional_day15 | 128.32 | 44 |
GSM1296048 | V_lesional_day15 | 135.8 | 45 |
GSM1296059 | A_lesional_day43 | 150.23 | 48 |
GSM1296066 | G_lesional_day43 | 190.87 | 50 |
GSM1296060 | R_lesional_day43 | 87.8 | 40 |
GSM1296063 | U_lesional_day43 | 201.46 | 52 |
GSM1296064 | E_lesional_day43 | 179.37 | 51 |
GSM1296067 | H_lesional_day43 | 124.33 | 42 |
GSM1296062 | M_lesional_day43 | 92.18 | 40 |
GSM1296068 | Q_lesional_day43 | 179.7 | 48 |
GSM1296050 | C_lesional_day43 | 41.47 | 27 |
GSM1296057 | D_lesional_day43 | 33.61 | 26 |
GSM1296052 | I_lesional_day43 | 43.62 | 31 |
GSM1296054 | J_lesional_day43 | 34.73 | 25 |
GSM1296049 | K_lesional_day43 | 37.2 | 27 |
GSM1296055 | W_lesional_day43 | 78.06 | 37 |
GSM1296053 | X_lesional_day43 | 37.39 | 27 |
GSM1296058 | Z_lesional_day43 | 103.54 | 43 |
GSM1296051 | F_lesional_day43 | 54.95 | 32 |
GSM1296056 | O_lesional_day43 | 67.05 | 37 |
GSM1296065 | S_lesional_day43 | 125.73 | 45 |
GSM1296061 | T_lesional_day43 | 126.76 | 44 |
GSM1296095 | A_non-lesional_pre-dose | 215.81 | 54 |
GSM1296120 | B_non-lesional_pre-dose | 89.92 | 37 |
GSM1296077 | C_non-lesional_pre-dose | 39.12 | 28 |
GSM1296093 | D_non-lesional_pre-dose | 48.49 | 30 |
GSM1296104 | E_non-lesional_pre-dose | 136.31 | 46 |
GSM1296079 | F_non-lesional_pre-dose | 13.92 | 12 |
GSM1296108 | G_non-lesional_pre-dose | 155.38 | 47 |
GSM1296110 | H_non-lesional_pre-dose | 145.13 | 45 |
GSM1296081 | I_non-lesional_pre-dose | 73.43 | 39 |
GSM1296091 | J_non-lesional_pre-dose | 81.05 | 39 |
GSM1296075 | K_non-lesional_pre-dose | 96.1 | 42 |
GSM1296112 | L_non-lesional_pre-dose | 203.77 | 50 |
GSM1296100 | M_non-lesional_pre-dose | 126.01 | 44 |
GSM1296087 | O_non-lesional_pre-dose | 62.24 | 37 |
GSM1296118 | P_non-lesional_pre-dose | 157.31 | 46 |
GSM1296114 | Q_non-lesional_pre-dose | 197.47 | 51 |
GSM1296097 | R_non-lesional_pre-dose | 123.75 | 45 |
GSM1296106 | S_non-lesional_pre-dose | 198.2 | 51 |
GSM1296102 | U_non-lesional_pre-dose | 116.72 | 42 |
GSM1296122 | V_non-lesional_pre-dose | 68.94 | 33 |
GSM1296089 | W_non-lesional_pre-dose | 94.23 | 39 |
GSM1296083 | X_non-lesional_pre-dose | 49.87 | 31 |
GSM1296116 | Y_non-lesional_pre-dose | 214.18 | 51 |
GSM1296085 | Z_non-lesional_pre-dose | 54.19 | 32 |